Squarepoint’s Jin Medical International ZJYL Stock Holding History

Squarepoint’s Portfolio ZJYL Stock Details ZJYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,662	Closed	-$86.4K	–	4782
2024 Q2	$86.4K	Buy	+1,662	New	+$105K	﹤0.01%	3823

Other funds holding ZJYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Squarepoint's ZJYL Position: Q3 2024 in Review

Squarepoint sold out of Jin Medical International (ZJYL) in Q3 2024, closing a stake of 1,662 shares — an estimated $86.4K sold.

Squarepoint first reported a position in ZJYL in Q2 2024 and held it in 1 quarter. The position peaked at $86.4K in Q2 2024. 12 funds tracked by Wall St. Rank hold ZJYL as of Q3 2024.

Squarepoint reported no remaining Jin Medical International position as of Q3 2024 after selling out during the quarter.
Squarepoint sold 1,662 Jin Medical International shares in Q3 2024, an estimated $86.4K.
Squarepoint first reported a position in Jin Medical International in Q2 2024 and held it in 1 quarter.
Squarepoint's Jin Medical International position peaked at $86.4K in Q2 2024.
12 funds tracked by Wall St. Rank held Jin Medical International as of Q3 2024.

Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.